CTC
QDEL icon

Central Trust Company’s QuidelOrtho QDEL Stock Holding History

Central Trust Company’s Portfolio QDEL Stock Details QDEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-85
Closed -$11K – 1458
2021
Q4 		$11K Buy
+85
New +$11.8K ﹤0.01% 1048
2021
Q1 		– Sell
-4,607
Closed -$828K – 1136
2020
Q4 		$828K Buy
4,607
+3,372
+273% +$749K 0.03% 300
2020
Q3 		$271K Buy
+1,235
New +$276K 0.01% 410

Other funds holding QDEL

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
SM
Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Central Trust Company's QDEL Position: Q1 2022 in Review

Central Trust Company sold out of QuidelOrtho (QDEL) in Q1 2022, closing a stake of 85 shares — an estimated $11K sold.

Central Trust Company first reported a position in QDEL in Q3 2020 and held it in 3 quarters. The position peaked at $828K in Q4 2020. 354 funds tracked by Wall St. Rank hold QDEL as of Q1 2022.

  • Central Trust Company reported no remaining QuidelOrtho position as of Q1 2022 after selling out during the quarter.
  • Central Trust Company sold 85 QuidelOrtho shares in Q1 2022, an estimated $11K.
  • Central Trust Company first reported a position in QuidelOrtho in Q3 2020 and held it in 3 quarters.
  • Central Trust Company's QuidelOrtho position peaked at $828K in Q4 2020.
  • 354 funds tracked by Wall St. Rank held QuidelOrtho as of Q1 2022.

Based on Central Trust Company's 13F filing for Q1 2022, filed 3 May 2022.